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Summary
Objective: To assess the predictive diagnostic added value of positron emission
tomography (PET) in preoperative epilepsy surgery evaluation for patients with
temporal lobe epilepsy (TLE).
Methods: Ameta-analysis of publications from 1992 to 2006 was performed. Forty-six
studies were identified that met inclusion criteria presenting detailed diagnostic test
results and a classified postoperative outcome. Studies exclusively reporting on
patients with brain tumors or on children were excluded.
Results: The analyses were complicated by significant differences in study design and
often by lack of precise patient data. Ipsilateral PET hypometabolism showed a
predictive value of 86% for good outcome. The predictive value was 80% in patients
with normal MRI and 72% in patients with non-localized ictal scalp EEG. In a selected
population of 153 TLE patients with a follow-up of >12 months PET correlated well
with other non-invasive diagnostic tests, but none of the odds ratios of any test
combination was significant.
Conclusion: Our data confirm that ipsilateral PET hypometabolism may be an indi-
cator for good postoperative outcome in presurgical evaluation of drug-resistant TLE,
although the actual diagnostic added value remained questionable and unclear. PET
does not appear to add value in patients localized by ictal scalp EEG and MRI.* Corresponding author at: Epilepsy Center Bethel, Maraweg 21, D-33617 Bielefeld, Germany. Tel.: +49 521 772 78800;
fax: +49 521 772 78806.
E-mail address: pohleden@gmx.net (B. Pohlmann-Eden).
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Prospective studies limited to non-localized ictal scalp EEG or MRI-negative patients
are required for validation.
# 2007 British Epilepsy Association. Published by Elsevier Ltd. All rights reserved.Introduction
A recent randomized controlled trial confirmed the
longstanding observation that surgery is superior to
prolonged medical therapy in refractory temporal
lobe epilepsy (TLE).1 The precondition for a success-
ful operation is the careful, precise identification of
the operationally defined epileptogenic zone (EZ),2
removal of which is expected to lead to seizure
freedom in a majority of patients.3—5 A previous
meta-analysis has described several predictive fac-
tors for surgical outcome.6 Nonetheless, the deci-
sion algorithm for epilepsy surgery is generally
based on empirical and center-specific logistics. In
the last two decades, many epilepsy surgery centers
have been developed world-wide with a variety of
center-specific diagnostic protocols.7—15 Today,
most cases can be diagnosed non-invasively, in par-
ticular when showing a concordant EEG and MRI
focus.16,17 Nevertheless, when the results from
non-invasive investigations are contradictory, some
patients still have a need for invasive intracranial
EEG recording (DEEG), with associated increased
costs and the risk of complications.18,19 Thus, the
search for non-invasive and cost-effective means of
seizure localization has been an important and com-
plex field of research.
Positron emission tomography (PET) has been used
for more than 25 years to assist in the localization of
epileptic foci.20—23 It is a versatile nuclear method
capable of providing dynamic information regarding
both local and general metabolism in the brain.24
Glucose metabolism is themost commonly measured
parameter using 18F-fluorodeoxyglucose (18F-FDG).
The characteristic finding in epilepsy is a regional
reduction in glucoseuptake (hypometabolism)during
the interictal state. A significant increase during ictal
seizure activity has been reported.24,25 There seems
to be a significant relation between the time of the
last seizure and the degree of observed regional
hypometabolism in epilepsy patients.26 The exact
reasons for the interictal hypometabolism are still
unclear.27 A common clinical presumption suggests
that cerebral hypometabolism reflects neuronal cell
loss, however, in epilepsy patients hypometabolism
more closely reflects the degree of cerebral dysfunc-
tion than it does actual structural compromise, part
of which may be due to loss of synaptic inputs, in
addition to the electrical activity generated within
the dysfunctional cortex.24 In this regard, extensionof hypometabolism to regions beyond the temporal
lobe is often seen in patients with TLE.10,28 There-
fore, PET images of regional hypometabolism should
be interpreted as presenting evidence of a dysfunc-
tional neural network.
By identifying and combining all available litera-
ture data from January 1992 to June 2006, we aimed
to identify the additional preoperative value of
interictal 18F-FDG PET in the decision making
process for epilepsy surgery in patients with TLE.Methods
An extensive computer literature search using
‘‘Medline’’ and ‘‘PubMed’’ was performed. Key
words were ‘‘Epilepsy surgery’’, ‘‘Epilepsy surgery
positron emission tomography’’, ‘‘Epilepsy surgery
PET’’, ‘‘Epilepsy surgery outcome’’. Each content
list of the journals identified by the publications was
used for a hand search. Literature reviews and the
reference lists of each publication were taken to
extend the search. The search was updated during
data analysis using a ‘‘PubMed-Crawler’’. All such
identified publications were considered and read in
the full text version.
The following inclusion criteria were defined:
(1) Only original data [both pro- and retrospec-
tive]. (2) Published from January 1992 to June 2006.
(3) Published in English. (4) The surgical outcome
had to be reported [Engel classification8 or classifi-
cation closely related] and diagnostic test results
described in detail. (5) Interictal 18F-FDG PET
reported as assessed method.
The following exclusion criteria were defined:
(1) Studies exclusively reporting on children. (2)
Studies published in pediatric journals. (3) Studies
exclusively reporting on patients with proven brain
tumors. (4) Studies exclusively reporting on patients
with ‘‘foreign tissue lesions’’ detected at MRI or
proven by pathology. (5) Studies exclusively report-
ing on extratemporal lobe epilepsy.
We obtained a summary of group analyses and a
new selected patient-based meta-analysis and
ensured that none of the patients was selected twice
by considering only the best documented or the
largest study published from each epilepsy center.
In a first step, the correlation values of the
studies were collected and the different findings
of the studies summarized to non-weighted overall
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ence methods and to overall positive predictive
values (PPVs).
The following catalogue of diagnostic settings
was defined for the reference methods:A: Good outcome, i.e. Engel Class I and II.
B: Invasive EEG recording (DEEG).
E: Ictal scalp EEG.E1: Non-localizing or non-lateralizing ictal scalp
EEG.M: MRI.
M1: Normal MRI.
S: Final decision, i.e. side of surgery alone.The PET findings were considered as localizing
when PET showed a concordant focus with the
reference method ipsilateral to the surgical side.
PPVs were calculated as ipsilateral findings of the
assessed method with good outcome concordant to
the surgical side or/and reference method. It had to
be clear from the papers that all patients actually
underwent epilepsy surgery after the presurgical
evaluation. Otherwise, when extraction and recon-
struction of surgical patients was not possible,
values were neglected for the overall correlations.
In a second step, a patient-based meta-analysis
was created when the studies provided detailed
case information for each individual patient. For
this attempt, data from group analyses were not
sufficient. Individual patients with a follow-up of at
least 12 months, with an age of at least 18 years and
without mass lesions were selected for a new study
population. In this meta-analysis, the results of ictal
EEG, MRI, PET and, when available, DEEG were
collected for each patient together with postopera-
tive outcome.
Firstly, inter-diagnostic test correlations were
obtained to assess the agreement among the tests
regardless of surgical side and outcome. In a second
step, the findings were categorized as concordant or
non-concordant with the surgical side as the stan-
dard of reference. The non-concordant group con-
tained non-lateralizing and discordant findings.
Then PPVs for outcome were calculated for each
diagnostic test and for any two or three test combi-
nations. Outcome was divided into Engel Class I
versus Engel Classes II—IV. Lastly, the odds ratios
of concordant versus non-concordant findings were
calculated for Class I outcome.Results
From more than 700 citations, we identified 83
potential studies. Forty-six studies were includedand 37 had to be excluded. Thirty-five publications
analyzed only TLE, whereas 11 reported on a mix-
ture of TLE and extratemporal lobe epilepsy
patients.
All studies reported patients well-selected by
some criteria. For comparisons of single diagnostic
tests and for correlation of correct localization with
the final resected side (however determined) was
used in 22 studies. In 18 studies, the patients were
limited to good outcome (A) for this attempt (see
Table 1 for details). In some studies, the FDG PET
methods were presumed to be an independently
assessed method and the results not taken into
the decision for determination of the surgical side.
In studies, where the FDG PET findings were taken
into the decision process it was not stated or was
unclear to what extent they influenced the decision
or why they were used. The criteria for localizing or
lateralizing findings were rarely described, espe-
cially in studies with visual PET image interpreta-
tion.
Postoperative follow-up ranged from 3 to 144
months. Outcome classifications used were either
the Engel classification or other classifications clo-
sely related to or based on the Engel scale. In the
overall series, PET study spatial resolution ranged
from 2.6 to 8.6 mm in plane at full width half—
maximum, the tracer injection dose from 1 to
15 mCi, and the time for data acquisition after
tracer injection from 5 to 60 min. Visual assessment
was described in 35 of the studies, visual assessment
and additional quantification in 11 and quantifica-
tion exclusively in 8 studies. The time of last seizure
occurrence before scanning was stated in only four
studies29—31,71 among the 41 papers published after
1994. Twenty-four different epilepsy centers
reported on 18F-FDG PET. Seven papers came from
Seoul, four each from Bethesda, Cleveland, India-
napolis and Melbourne, three from Durham and two
from each of Philadelphia, Tampa and Turku.
The identified studies revealed PET as a confir-
matory test. The presurgical evaluation protocols of
the studies did not identify a uniform procedure.
Some authors investigated all patients whereas
others only investigated specifically selected
patients. Only one study evaluated the impact of
PET findings for presurgical evaluation.32 Table 2
presents the results of the calculated overall corre-
lations of our defined catalogue of diagnostic set-
tings for ipsilateral PET hypometabolism in TLE
publications. Concordance values and the PPVs
were high for all diagnostic settings reflecting
well-selected patients in the publications, e.g.
86.37% of the patients with good outcome had an
ipsilateral PET finding. For patients requiring DEEG,
and those with non-localizing EEG or normal MRI the
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Table 1 Included studies
Author Year Epilepsy
center
Patients
(total no.)
Age mean;
range
(years)
‘‘No
mass
lesion’’
TLE
patients
PET Diagnostic
setting
reference
method
Surgery Outcome
 12
months
Postoperative
follow-up
minimum;
mean; range
(months)
Classification
Spatial
resolution
in mm
Injection
dose
(mCi)
Acquisition
of data
commencing
time after
injection (min)
Patient’s
last
seizure
Data
analysis
Achten et al. 46 1998 Gent 29 NA; 14—53 X X 8.1/5.0 5 30 NA V C 17 12 NA; 6—36 E
Benbadis et al. 33 1995 Cleveland 25 32; 19—50 X X 5.8 5—10 40 NA V B 14 14 12; NA E
Blum et al. 74 1998 Phoenix 12 NA; 7—51 X X 6.0 10 27 NA V B 6 6 12; NA E
Carne et al. 68 2004 Melbourne 60 36; 18—58 X X 4.2 1—3 5—60 NA V E + [M or M1] 43 43 24; NA SF
Chapman et al. 69 2006 Cleveland 24 18; 2—49 X 13 NA NA NA NA NA E + M1 X X 6; 29; NA SF
Chee et al. 57 1993 Cleveland 40 32; 18—53 X X 5.8 5—10 40 NA V B or E 38 38 12; NA SF
Debets et al. 59 1997 Utrecht 23 34; 13—50 X X 5.0 7.5 30 NA V, SQ S X — 12; 6—30 E
Delbeke et al. 61 1996 Nashville 38 33  10;
15—59
— X 6.5 13 35 NA Q A + S X X 36  11; 18—58 E
DellaBadia Jr et al. 41 2002 Shreveport,
Indianapolis
69 35; 11—66 X 33 NA 10 NA NA V S X X 36; 22—48 E
Drzezga et al. 45 1999 Munich,
Michigan
49 37  9; NA — 27 NA 10 NA NA V, SSP A + S 30 NA NA E
Dupont et al. 63 2000 Paris 30 29; NA X X 5.8 8/70 kg 30 NA Q A + S X X 42; 25.2—63.6 E
Gaillard et al. 47 1995 Bethesda 18 29; 15—41 X X 5.5 5 30 NA Q B or E 9 8 28; 11—38 SF
Hajek et al. 60 1993 Zurich 25 32; 14—52 X X 8.0 4.8;
2.9—10
45 NA V, Q B or E 24 20 21.2; 6—38 E
Heinz et al. 70 1994 Durham 27 28.2; 11—59 X X 8.6 10 30 NA V S X X 12; 21; NA SF
Helveston et al. 34 1996 Tampa 16 30; 14—45 X X 6—8 5—15 40  10 NA V A + [B or E] X X 12; NA E
Ho et al. 29 1996 Melbourne 35 31.9; 10—52 X X 6.5 7—10 30 24 h V A + S 30 16 12; NA E
Hong et al. 35 2002 Seoul 41 28.0  7.6;
8—44
X 11 6.1 10 60 NA V A + B X NA 33.34  13.44; NA E
Huijin et al. 36 2001 Shanghai 15 27; 10—54 X X NA NA 30 NA V A + [B or E] X — NA; 3—18 SF
Hwang et al. 42 2001 Seoul 117 28; 12—46 X 50 6.1 10 60 NA V A + S X X 34; 12—67 E
Kilpatrik et al. 48 1997 Melbourne 75 37  10;
15—58
X X NA NA NA NA V M 24 24 24; 12—32 E
Knowlton et al. 64 1997 San Francisco 25 38; 14—56 X X 3.5 10 45 NA V, Q B or E 24 24 23; 18—31 E
Lamusuo et al. 49 1999 Turku 9 24.4; 13—40 — X 6.5 0.1/kg 55 NA Q S 6 6 36; NA E
Lamusuo et al. 50 2001 Turku 16 32.8  10.9;
15—46
X X 6.5 0.1/kg 55 NA Q S X X 12; NA E
Lee et al. 71 2005 Seoul 89 25.6  7.9;
8—56
X 31 6.1 10 60 24 h SPM B + M1 X X 24; 42.
48  22.2
E
Leiderman et al. 51 1992 Bethesda 28 NA; 27—49 NA X 6.0 5 30 NA Q B or E 12 12 12; NA SF
Manno EM et al. 30 1994 Philadelphia 43 NA; 18—51 X X 5.5 8/70 kg NA 12 h V, Q A + S X X 12; NA SF
Mastin et al. 37 1996 Tampa 42 29.8; 13—45 X 29 5—7 5—15 30—50 NA V S NA NA 12; 13—42 E
Mikuni et al. 52 1997 Kyoto 3 30, 30, 25 X X NA NA NA NA V A + S X X 12, 22, 23 SF
Nagarajan et al. 39 1996 New York 2 26, 25 X X NA NA 30 NA V, Q A + S X X 36, 37 SF
O’Brien et al. 32 2001 Melbourne 55 34; 16—63 X 41 5.4 1—3 45—60 NA V, ACI S 24 — 6; NA E
Park et al. 38 2001 Seoul 33 28; 17—46 X X NA 10 NA NA V, Q A + M X X 12; NA E
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.8concordant localizing PET values were 66.67%,
74.34% and 76.83%, respectively, with PPVs of
74.80%, 72.94% and 80.03%.
It was not possible to distinguish between localiz-
ing and lateralizing findings, because this informa-
tion was too often hidden, not separated or
considered as the same in the identified studies.
Also, for normal or non-localizing PET findings
analyses could not be performed, because most
investigators placed little attention on and did
not state clearly the outcome in this subgroup.
The significance of ‘‘false’’ PET findings, e.g.
extratemporal or contralateral temporal, in the
otherwise well-localized TLE patients could not
really be determined, with presented cases very
rare. Only six studies33—38 with 131 temporal surgery
patients together reported nine patients (6.87%)
with ‘‘false’’ PET findings. Two studies33,37 found
one such patient each with poor outcome. The
remaining studies included only patients with good
outcome, so that seven patients had a good post-
operative outcome. Two case reports39,40 showed
another four separately reported patients with good
outcome falsely localized by PET. Carne et al.68
reported an MRI-negative patient with a false PET
finding and good postoperative outcome. Further-
more, two non-localized PET patients with normal
MRI had a good postoperative outcome.68
Selected TLE population
From the 46 included PET studies, 14 publica-
tions31,34,39,40,46—55 provided detailed patient infor-
mation. Finally, 153 TLE patients were selected for
the meta-analysis of PET and summarized in an
un-weighted way. Results were found for ictal scalp
EEG, MRI and PET in all patients, and for DEEG
recording in 41 patients.
Seventy-eight patients were operated on the left
temporal lobe and 75 patients on the right temporal
lobe. Overall, 77.8% (119/153) of patients became
seizure-free (Engel Class I) and 22.2% (34/153) were
not seizure-free (p = 0.176). The left versus right
odds ratio for Class I outcome was 0.569 [0.261—
1.241].
In the 153 patients, regardless the final defined
surgical side and surgical outcome, the ictal scalp
EEG was in agreement with MRI in 106 patients
(69.3%). Nineteen patients with a non-localizing
ictal scalp EEG showed a localizing MRI in 15
(78.9%) cases, whereas ictal scalp EEG showed a
focus in 24 of 28 (85.7%) patients with normal MRI.
Four patients with bitemporal MRI abnormalities
had a localized focus on EEG. Disagreement
between EEG and MRI was seen in only four
patients.
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Table 2 Overall correlations for PET
Diagnostic setting
as standard of
reference
Sensitivity ‘‘Concordant to side of
surgery’’
PPV ‘‘For Good outcome (i.e. Engel Class I
and II)’’
Concordant
PET
Total
localized
% Good
outcome
Concordant
PET
%
A 488 465 {30} 86.37 — — —
S 482 578 {28} 83.39 402 467 {28} 86.08
B 120 180 {18} 66.67 95 127 {17} 74.80
E 219 247 {14} 88.66 132 147 {12} 89.80
E1 84 113 {15} 74.34 62 85 {14} 72.94
M 199 237 {21} 83.97 184 212 {21} 86.79
M1 63 82 {16} 76.83 49 61 {15} 80.03
{} Number of combined studies which can differ among calculated values.
For definition of letters regarding the diagnostic setting see above.PET and ictal scalp EEG agreed in 115 (75.2%)
patients. Nineteen of 22 (86.4%) PET negative
patients had an epileptiform focus on EEG, whereas
16 of 19 (84.2%) non-localized EEG patients had
temporal hypometabolism on PET. Three patients
had disagreement between ictal scalp EEG and PET.
For MRI and PET, there was an agreement in 105
(68.6%) patients. Twenty-three of 28 (82.1%) normal
MRI patients revealed an area of PET hypometabo-
lism, whereas MRI was abnormal in 17 of 22 (77.3%)
patients with normal PET. In the four patients with
bitemporal MRI, there was hypometabolism in all
patients. Four patients had disagreement between
MRI and PET.
In the 41 DEEG patients, ictal scalp EEG agreed
with DEEG in 22 cases (53.4%). All 18 normal or non-
lateralized ictal scalp EEG seizure activity was later-
alized to one side by DEEG. There was agreement
among DEEG and MRI in 32 (78%) patients and dis-
agreement in one patient. In all eight patients with
normal MRI scans seizure activity was detected by
DEEG. Agreement between PETand DEEG was found
in 19 (46.3%) patients. DEEG lateralized seizure
activity to one side in all nine normal PET patients.
Disagreement was seen in three patients. Table 3
shows the statistics for these inter-diagnostic test
correlations. Cohen’s Kappa showed moderate
agreement among the non-invasive tests.Table 3 Statistics for the inter-diagnostic test correlation
Two-sided Significance
Fisher Mc Nem
Ictal EEG & MRI <0.05 0.771
Ictal EEG & PET <0.05 0.256
MRI & PET <0.05 0.193
Ictal EEG & DEEG <0.05
MRI & DEEG <0.05
PET & DEEG <0.05
a Includes four cases with bitemporal MRI abnormalities judged tAll diagnostic tests correlated well with the final
defined surgical side as seen in Table 4. Apart from
the subgroup of 41 DEEG cases, most concordant
cases were detected by ictal scalp EEG, followed by
PETand then by MRI. Discordant findings were infre-
quent, but mostly found at PET or MRI.
The PPVs of single concordant findings for Class I
outcome were high and in a similar range for all
non-invasive tests including PET. PPVs for concor-
dant two test combinations and in cases of non-
concordant plus concordant findings were also high
(Table 5). The PPVs for the non-lateralizing non-
invasive tests were 68.4% (13/19) for EEG, 68.8%
(22/32) for MRI and 77.3% (17/22) for PET. Surpris-
ingly, against general clinical experience, all cases
with non-invasive discordant findings at any test
had a Class I outcome. PPV for the all concordant
EEG, MRI and PET combination was 77% (67/87). If
the ictal EEG was non-concordant in this three
tests combination and MRI and PET were concor-
dant the PPV was 91.7% (11/12). For a non-con-
cordant MRI or PET finding, the PPVs were 83.3%
(20/24) and 86.6% (13/15), respectively. The over-
all PPV of a concordant PET finding was 77.5%
(31/40) when MRI or EEG or even both were non-
concordant.
The odds ratios of concordant versus non-concor-
dant findings for Class I outcome are demonstrateds
Cramer-V Cohen’s Kappa
ar
0.549 0.510 a
0.589 0.591
0.546 0.504 a
0.690
0.852
0.732
he same as normal MRI cases.
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Table 5 PPVs for the single diagnostic tests, two-concordant tests and the two-test combination with one non-
concordant test
‘Prior’ diagnostic test PPVs for Class I outcome concordant
DEEG (%) PET (%) MRI (%) EEG (%)
Alone 70.7 (29/41) 77.2 (98/127) 79.9 (94/118) 78.9 (105/133)
ncEEG 73.7 (14/19) 75.0 (12/16) 87.5 (14/16)a —
cEEG 68.2 (15/22) 77.7 (87/112) 78.4 (80/102) —
ncMRI 44.4 (4/9) 71.4 (20/28) — 80.6 (25/31)
cMRI 78.1 (25/33) 78.8 (78/99) — —
ncPET 75.0 (9/12) — 84.2 (16/19) 85.7 (18/21)
cPET 69.0 (20/29) — — —
Prior diagnostic test, c: concordant; nc: non-concordant.
a Marginally significant (p = 0.04).
Table 4 Diagnostic tests and surgical side
Concordant to
side of surgery
Non-concordant Total Cramer-V
Non-lateralizing Discordant
Ictal EEG 133 19 1 153 0.924
MRI 118 32 3 153 0.850
PET 127 22 4 153 0.871
DEEG 41 — — 41 1.0in Fig. 1. Patients with a concordant PET scan had a
0.8 better chance to become seizure-free than
patients with a non-concordant PET scan, but the
95% CI ranged from 0.279 to 2.322 and was not
significant. When EEG and MRI were both non-
concordant, in these four patients with poorFigure 1 Odds ratios of concordant versus non-noncordant fi
their combinations. Prior (first or second) diagnostic test,
concordant MRI to non-concordant EEG was statistically sign
setting: either EEG or MRI was non-concordant plus the other
non-concordant.outcome three patients had a concordant PET and
one a non-lateralizing PET scan. The overall odds
ratio for PET was 1.292 [0.282—5.908] for cases
when either EEG or MRI was non-concordant and
the other test was concordant, or even when both
tests were non-concordant.ndings for Class I outcome of single non-invasive tests and
c: concordant; nc: non-concordant. (*)Combination of
ificant ( p = 0.003). (#)Any non-concordant preoperative
test was concordant, plus the cases when both tests were
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PET provides a rich source of information about
physiological functions of the human brain, and
might be seen as complementary to those diagnostic
imaging technologies that are used to assess anato-
mical details. However, while PET has an established
role in many areas of medical research, its place and
potential application in routine neurological care is
less clear. By identifying and combining all available
literature data we hoped to illuminate the picture in
the decision making process for epilepsy surgery of
TLE and aimed to identify what additional preopera-
tive value PET may offer in this setting.
Due to the fact that the individual studies on the
preoperative evaluation for epilepsy surgery often
presented a small number of patients we conducted
a meta-analysis. Drawing on patients studied in
many trials a meta-analysis has the power to detect
small but clinically significant effects and can give
more precise estimates of the size of any effects
uncovered. This is especially important if we want
to look for beneficial or deleterious effects in a
specific subgroup of patients.
For understanding meta-analyses, it is impor-
tant to consider that a meta-analysis is always only
as good as the quality of the underlying studies.
The method has to be performed with extreme
caution, because there is plenty of scope for
biases. Because of the mixing of diverse studies,
heterogeneity is an unavoidable fact of meta-ana-
lysis. The question is not whether it is present
but whether its extent seriously undermines the
conclusions being drawn.
Our identified individual studies showed huge
heterogeneity and many discrepancies. The most
important difficulty in performing our meta-analysis
was that the data of the individual studies were not
presented in an obvious and extractable way to
create detailed subgroups. The information about
age, follow-up and the results of the diagnostic tests
was often hidden. Retrospectively, the connection
of the diagnostic test results to outcome could often
not be obtained. The interesting subgroup of non-
localizing findings at any diagnostic test was under-
represented in the individual studies. These
patients were often not compared to outcome or
to the results of any other diagnostic test. However,
this information is needed to calculate odds ratios.
Furthermore, detailed presentation of the patients
was not available in all studies.
Unfortunately, it was thus only possible to sum-
marize the results of the single studies in an un-
weighted way. However, it was possible to create a
specific patient-based TLE study population from
the individual studies.All studies clearly revealed theconfirmatory useof
PET. Concordance to any standard reference or to
DEEG was quite good in the well-localized TLE
patients. PPVs of PET for good outcome are high in
TLE patients. This was supported by our un-weighted
summarizing of the studies. Even in patients with
normal MRI or non-localizing ictal scalp EEG findings
concordance and PPVs for good outcome were high
withPET.Our selectedTLEpopulation showed that all
PET findings associated with good outcome had simi-
lar high PPVs. All other non-invasive tests repre-
sented similar percentages. The distribution of
findings was similar among good and bad outcome
patients. No specific combination of the tests had a
significant odds ratio apart from the combination of
non-concordant EEG plus concordant MRI. However,
the number of patients with this constellation was
low, and so may not be representative. High inter-
test agreementwasobserved, andmany complemen-
tary findings of other tests were observed when one
test was normal or non-localizing.
Hypometabolism is neither specific for epilepsy
nor for underlying hippocampal sclerosis or any
other underlying pathologic lesion.50,55,57,58 The
area of hypometabolism often shows greater extent
than foci demonstrated by EEG or MRI.53,59 Although
PET is the most sensitive diagnostic method, it
provides only approximate localization of the EZ
and is not adequate for precise localization.43 It
may be useful for differentiating between TLE of
mesial or lateral origin.60 Temporal hypometabolism
of the mesial temporal lobe may be a better pre-
dictor for seizure control than lateral temporal
hypometabolism.61 Furthermore, hypometabolism
over the uncus or in the anterolateral lobe have
been reported as independent predictors.30,62
Patients with restricted temporal hypometabolism
were described to be more likely seizure-free in two
studies,30,54 although Radtke et al.58 disagreed and
found a greater extent beyond the temporal lobe to
be predictive for good outcome. A more recent
study63 indicated the pattern of hypometabolism
in a specific network to achieve better prediction
than hypometabolism in a single temporal region.
The value for defining the extent of the surgical
resection and for the decision whether an en bloc
anterior temporal lobectomy or a selective mesial
resection should be performed remains unclear.53
PET did not provide any new information in
patients well-localized by ictal scalp EEG and con-
cordant MRI,64,65 and can even confuse the picture
when showing misleading findings contralateral to
the EZ in patients rendered seizure-free with
surgery, although misleading cases are rare and
sometimes due to performance of the test during
the ictal state.39,40
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surgery is a successful treatment in TLE patients with
normal MRI because of good postoperative seizure
control, even without the localization aid of PET.67
The use of PET for patients with normal MRI has been
discussed by several authors. PET investigators
stressed the role of PET as a complementary tool
to MRI and the procedure of choice for MRI-negative
TLE patients.32,34—37,42,43,47,49,50,54,55,59,64,65,68—73
The selective use in normal MRI patients was recom-
mended to reduce costs.34,36,41,47 Performancebased
on the affordability to patients was suggested.36 For
PET, we found a PPV of 80% in the group analysis and
71% in the patient-based meta-analysis in the setting
of MRI-negative TLE patients. This finding was sup-
ported by recent studies68,69,71,73 with a study popu-
lation restricted to patients with normal MRI. For our
analyses, those studies had to be excluded for the
calculation of values because of unextractable data
regarding diagnostic test results and outcome, and
furthermore because of included studies published
from the same epilepsy center. Significant more
widespread hypometabolism was found in MRI-nega-
tive PET-positive TLE patients.68 Also, localization by
PET and interictal scalp EEG has been shown to be
significantly related to seizure-free outcome in
patients with normal MRI.71 In only one study was
the actual clinical impact of PET assessed in TLE
patients with non-localizing scalp EEG or normal
MRI.32 PET added information in these cases and
yielded independent prognostic information from
that provided by MRI.
It has also been reported that PET frequently
showed bitemporal hypometabolism (BTH) in
patients with conflicting scalp EEG and MRI findings,
associated with worse outcome. It was recom-
mended that BTH should be an indication for DEEG
and a contraindication to perform surgery on non-
invasive evaluation alone.74 Unilateral PET tem-
poral hypometabolism shows excellent correlation
with ictal seizure onset on scalp or invasive EEG.61
Although temporal hypometabolism is not specific
for epilepsy, the finding of unilateral temporal hypo-
metabolism has a high probability for the patient
having unilateral TLE.57 So patients with normal,
non-localizing, non-lateralizing or even incorrect
ictal scalp EEG could benefit from interictal
PET.32,35,42,43,49,52,57,59,65,72 Ictal EEG may be unne-
cessary or might even provide misleading informa-
tion, when PETand MRI show localization consistent
with interictal EEG.75 However, EEG data are still
mandatory for surgery planning. PETwas capable of
distinguishing frontal and temporal foci in a study of
patients with lateralized but not localized surface
ictal video EEG.75 In patients with interictal bitem-
poral epileptiform discharges PET is of reducedvalue as compared to unilateral epilepsy and should
be performed as an adjunct to DEEG.33 Lateralizing
convergent PET did not substantially increase the
probability of successful postoperative outcome in
these patients. Two studies suggested the use of
DEEG in patients with misleading MRI or PET, the
latter findings indicating poor prognosis, whereas
normal findings did not33,64.
DEEG is the gold standard in difficult or conflict-
ing cases of non-invasive evaluation. Almost all PET
investigators performed DEEG in these cases. The
relationship of PETwith respect to DEEG is not clear
from the studies, although here it was presumed by
the studies that it could reduce the need for
DEEG.49,76 Since the integration of PET and volu-
metric MRI in the routine presurgical work-up at the
epilepsy center in Indianapolis, DEEG was per-
formed less and better outcomes were achieved
as compared to the time period before introduction
of PET.56 Theodore et al.76 stated that it is difficult
to determine how decisions would have been
altered on the basis of PET, but it might have been
unnecessary to implant the right hemisphere in
three patients who had right sided and in five
patients who had bilateral subdural electrodes,
reducing the total number of hemispheres
implanted from 18 to 10 and patients implanted
from 13 to 10. The presence of hypometabolism
when performed in patients who underwent DEEG
was related to better outcome, in contrast to
the scalp EEG subgroup. Greater inferior lateral
temporal hypometabolism asymmetry was an inde-
pendent predictor for seizure freedom.75 Further-
more, patients with PET hypometabolism requiring
DEEG were more likely to become seizure-free
after surgery compared to patients with a normal
PET scan.54,58,77 However, the need for DEEG, in
itself, is associated with a greater likelihood for
poor prognosis.33,77 The value for planning invasive
recording was recommended in TLE.35,49,59 PET
could help to exclude additional extratemporal foci
in TLE.49
To draw conclusions from this work is quite diffi-
cult and there remains a lack of clear evidence.
There is no accepted gold standard for localization
of the EZ. The most accepted might be DEEG, but it
is not reasonable to perform DEEG in all patients due
to the previously stated reasons. Good outcome is
the goal of the presurgical evaluation. The reported
number of patients with poor outcome was low.
Reasons for a non-favorable outcome in patients
seemingly well-localized can be an incorrectly loca-
lized focus, an undetected additional focus, insuffi-
cient postoperative drug treatment, or that the
surgeon could not or did not resect enough tissue,
e.g. in so-called ‘‘eloquent’’ brain areas.
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good and poor outcome patients. In other words,
non-localizing or discordant findings do not neces-
sarily mean a patient will not become seizure-free,
and vice versa. The explanation for a discordant
abnormality might be that there exist independent
seizure foci, that the finding reflects seizure spread
or that the technical performance of the procedure
was flawed. Discordant findings were rare in these
papers, although whether this reflects truly rare
occurrences in the population or underreporting is
unclear.
The evaluation process is a consensus. Higher
concordance gives greater certainty that the EZ is
focal. Dellabadia et al.41 showed a trend to better
outcome when three tests are concordant. Labiner
et al.78 found that concordance becomes signifi-
cant when four tests or more are used and
assessed. It was suggested that no non-invasive
test should be considered as redundant.77 How-
ever, when a given test has a high diagnostic
accuracy but correlates well with other tests,
the test in question might not provide any addi-
tional corroborating information and could argu-
ably not be considered as a confirmatory test.79 No
single test is solely sufficient to make the localiza-
tion diagnosis for epilepsy surgery.72 For PET,
values clearly differ among TLE and extratemporal
lobe epilepsy. The value of the greater extent of
abnormality found on PET remained unclear. The
guidance for DEEG is questionable and not proven
with respect to considerations of cost-effective-
ness. Also, evolution in neuroimaging techniques
has to be considered, e.g. an MRI that was eval-
uated as normal 6 years ago might be judged as
localizing today with better high-resolution MRI.
Therefore, caution is required regarding this point
when spanning early MRI data.
In conclusion, ipsilateral PET hypometabolism
showed high concordance and high predictive
values for good outcome, even in cases requiring
DEEG with normal MRI or with non-localizing
ictal scalp EEG. Our data confirm that ipsilateral
PET hypometabolism may be an indicator for
good postoperative outcome in the presurgical
evaluation of drug-resistant temporal lobe epi-
lepsy, although under cost-effectiveness aspects
the role and value remain questionable and
unclear. PET does not appear necessary in patients
localized by ictal scalp EEG and MRI. Larger
prospective multicenter studies with a specific
question, e.g. the utility of PET in patients with
non-localizing ictal scalp EEG and/or MRI should
be obtained.
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